Sign Up to like & get
recommendations!
1
Published in 2018 at "Genome Medicine"
DOI: 10.1186/s13073-018-0612-8
Abstract: Editorial summaryInhibitors of poly(ADP-ribose) polymerase (PARPi) have entered the clinic for the treatment of patients with cancers that lack homology-directed DNA repair, but drug resistance remains a clinical hurdle. Recent advances in the identification of…
read more here.
Keywords:
mechanisms parp;
parp inhibitor;
resistance;
resistance cancer ... See more keywords